Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00153491
Other study ID # CDC-NCID-3602
Secondary ID
Status Completed
Phase Phase 4
First received September 8, 2005
Last updated September 8, 2005
Start date August 2002
Est. completion date August 2006

Study information

Verified date September 2005
Source Centers for Disease Control and Prevention
Contact n/a
Is FDA regulated No
Health authority United States: Federal GovernmentTanzania: National Institute for Medical Research
Study type Observational

Clinical Trial Summary

This is a study of how well caregivers of children with malaria adhere to the recommended regimen for lumefantrine-artemether (LA). Children were randomly assigned to either a group receiving directly observed treatment in hospital or to a group treated at home by the routine caregiver (typically, patient's mother). Clinical/parasitologic, hematologic, pharmacologic and qualitative parameters were monitored over a 28-day follow-up period and are used to evaluate drug adherence.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date August 2006
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A to 59 Months
Eligibility Inclusion criteria:

- age < 5 years of age.

- axillary temperature >= 37.5oC

- unmixed infection with P. falciparum of between 1,000 and 250,000 asexual parasites/mm3 as determined by microscopic examination of thick, or thick and thin peripheral blood smears.

- parent/guardian's informed consent and willingness to participate in the study

Exclusion criteria:

- any evidence of severe or complicated malaria that would require hospitalization for treatment.

- reported allergy to any antimalarial drugs, including artemisinin derivatives and sulfa drugs.

Study Design

Observational Model: Defined Population, Time Perspective: Longitudinal


Related Conditions & MeSH terms


Intervention

Drug:
artemether-lumefantrine


Locations

Country Name City State
Tanzania Mkuranga District Hospital Mkuranga Mkuranga District

Sponsors (2)

Lead Sponsor Collaborator
Centers for Disease Control and Prevention Ifakara Health Research and Development Centre

Country where clinical trial is conducted

Tanzania,